Skip to main content
Summary
Profile
Financials
Events
Ownership
Options

Company Info

Industry Biotechnology
Sector Health Technology
Employees 735
CEO Mr. Timothy R. Wright
Address 1775 West Oak Commons Court NE , Marietta, GA 30062
Phone 1.770.651.9100
Website www.mimedx.com

MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane; EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matri derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.

Competitors

Company Name 3 Month
%Change
1 Year
%Change
MiMedx Group, Inc. -46.94% 9.17%
BellRing Brands, Inc. -23.22% 12.37%
ImmunoGen, Inc. -16.49% -10.38%
Heron Therapeutics, Inc. -18.03% -48.47%
Singular Genomics Systems, Inc. -23.64% n/a

Statement Summary

as of 1:00 ET PM 11/26/2021
Total Assets (MRQ) 180.5 M
Total Liabilities (MRQ) 93.8 M
Shareholders’ Equity (MRQ) 86.7 M
Total Revenue (Annual) 63.1 M
Net Income (Annual) -2.3 M

Earnings And Estimates

as of 1:00 ET PM 11/26/2021

Current Qtr EPS Estimate -0.07
Current FY EPS Estimate -0.22
Long Term EPS Growth Estimate 15.00
Next Expected Earnings Date //

MDXG vs S&P 500

as of 11/26/2021
Relative To
S&P 500
MDXG
4 Weeks n/a n/a
12 Weeks n/a n/a
YTD n/a n/a

Earnings Surprises

as of 1:00 ET PM 11/26/2021
Fiscal Quarter Estimate Actual Surprise
09/2021 -0.10 0.02 -124.27%
06/2021 -0.10 0.02 -120.61%
03/2021 -0.19 -0.09 -52.63%
03/2018 0.09 0.09 0.00%
12/2017 0.11 0.10 -1.59%
09/2017 0.08 0.08 -3.53%
06/2017 0.07 0.07 +3.59%
03/2017 0.07 0.07 +5.09%

Financial Strength

as of 1:00 ET PM 11/26/2021
Pre-Tax Margin -3.23
Net Margin 87.72
Operating Margin -1.70
Return On Equity -30.50
Return On Assets -14.77
Inventory Turnover (TTM) 3.98
Sales Growth (MRQ) 5.80

Ratios

as of 1:00 PM ET 11/26/2021
Price/Earnings (TTM) n/a
Price/Book (MRQ) 0.00
Price/Cash Flow (TTM) 0.00
Book Value (MRQ) -0.05
Quick Ratio (MRQ) 3.09
Current Ratio (MRQ) 3.36
Total Debt/Equity (MRQ) 0.55

Short Interest

as of 4:00 PM ET 11/29/2021
% Short - 0.00%
% Remaining Float - 100.00%
Current Last Month
Short Interest Date n/a n/a
Short Interest Shares 0 0
Short Interest Ratio 0.0 0.0
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00 0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00 0,0.00
Cash from
Activities
0,0.00 0,0.00
Cash from
Fin. Activities
0,0.00 0,0.00

TOTAL ASSETS

TOTAL LIABILITIES

TOTAL EQUITY

Balance Sheet

M Y
ASSETS
Cash And Equivalents 0,0.00
Receivables 0,0.00
Inventories 0,0.00
Other Current Assets 0,0.00
Total Current Assets 0,0.00
Property, Plant & Equipment, Gross 0,0.00
Accumulated Depreciation & Depletion 0,0.00
Property, Plant & Equipment, Net 0,0.00
Intangibles 0,0.00
Other Non-Current Assets 0,0.00
Total Non-Current Assets 0,0.00
TOTAL ASSETS 0,0.00
Liabilities & Shareholder Equity
Accounts Payable 0,0.00
Short Term Debt 0,0.00
Total Current Liabilities 0,0.00
Long Term Debt 0,0.00
Deferred Income Taxes 0,0.00
Other Non-Current Liabilities 0,0.00
Minority Interest 0,0.00
Total Non-Current Liabilities 0,0.00
Preferred Stock Equity 0,0.00
Common Stock Equity 0,0.00
Common Par 0,0.00
Additional Paid In Capital 0,0.00
Cumulative Translation Adjustment 0,0.00
Retained Earnings 0,0.00
Treasury Stock 0,0.00
Other Equity Adjustments 0,0.00
Total Capitalization 0,0.00
TOTAL EQUITY 0,0.00
TOTAL LIABILITIES & STOCK EQUITY 0,0.00
Total Common Shares Outstanding 0,0.00
Preferred Shares 0,0.00
Treasury Shares 0,0.00
Basic Weighted Shares Outstanding 0,0.00
Diluted Weighted Shares Outstanding 0,0.00
Number Of Employees 0,0.00
Number Of Part-Time Employees 0,0.00

TOTAL REVENUES

EBT Excluding Unusual Items

NET INCOME

Income Statement

M Y
Sales 0,0.00
Cost Of Sales 0,0.00
Gross Operating Profit 0,0.00
Selling, General, And Administrative Expenses 0,0.00
Research & Development 0,0.00
Operating Income Before D & A (EBITDA) 0,0.00
Depreciation & Amortization 0,0.00
Interest Income 0,0.00
Other Income - Net 0,0.00
Special Income / Charges 0,0.00
Total Income Before Interest Expenses (EBIT) 0,0.00
Interest Expense 0,0.00
Pre-Tax Income 0,0.00
Income Taxes 0,0.00
Minority Interest 0,0.00
Net Income From Continuing Operations 0,0.00
Net Income From Discontinued Operations 0,0.00
Net Income From Total Operations 0,0.00
Extraordinary Income/Losses 0,0.00
Income From Cum. Effect Of Acct. Change 0,0.00
Income From Tax Loss Carryforward 0,0.00
Other Gains / Losses 0,0.00
Total Net Income 0,0.00
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Preferred Dividends 0,0.00
Net Income Available To Common 0,0.00
Basic EPS From Continuing Ops. 0,0.00
Basic EPS From Discontinued Ops. 0,0.00
Basic EPS From Total Operations 0,0.00
Basic EPS From Extraordinary Inc. 0,0.00
Basic EPS From Cum Effect Of Accounting Change 0,0.00
Basic EPS From Tax Loss Carryf'd. 0,0.00
Basic EPS From Other Gains (Losses) 0,0.00
Basic EPS, Total 0,0.00
Basic Normalized Net Income/Share 0,0.00
EPS From Continuing Ops. 0,0.00
EPS From Discontinued Ops 0,0.00
EPS From Total Ops. 0,0.00
EPS From Extraord. Inc. 0,0.00
EPS From Cum Effect of Accounting Change 0,0.00
EPS From Tax Loss Carfd. 0,0.00
EPS From Other Gains (L) 0,0.00
EPS, Total 0,0.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Dividends Paid Per Share 0,0.00

CASH FROM OPERATIONS

CASH FROM INVESTING ACTIVITIES

CASH FROM FINANCING ACTIVITIES

Cash Flow Statement

M Y
Cash Flow From Operating Activities
Net Income (Loss) 0,0.00
Operating Gains/Losses 0,0.00
Gross Operating Profit 0,0.00
(Increase) Decrease In Receivables 0,0.00
(Increase) Decrease In Inventories 0,0.00
(Increase) Decrease In Other Current Assets 0,0.00
(Decrease) Increase In Other Current Liabilities 0,0.00
(Increase) Decrease In Other Working Capital 0,0.00
Other Non-Cash Items 0,0.00
Net Cash From Continuing Operations 0,0.00
Net Cash From Discontinued Operations 0,0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 0,0.00
Sale Of Property, Plant & Equipment 0,0.00
Cash Used For Investing Activities
Sale Of Short-Term Investments 0,0.00
Purchases Of Property, Plant & Equipment 0,0.00
Acquisitions 0,0.00
Purchases Of Short-Term Investments 0,0.00
Other Cash From Investing Activities 0,0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 0,0.00
Issuance Of Debt 0,0.00
Cash Used For Financing Activities
Issuance Of Capital Stock 0,0.00
Repayment Of Long-Term Debt 0,0.00
Repurchase Of Capital Stock 0,0.00
Payment Of Cash Dividends 0,0.00
Other Financing Charges, Net 0,0.00
Net Cash From Financing Activities 0,0.00
Effect Of Exchange Rate Changes 0,0.00
Net Change In Cash & Cash Equivalents 0,0.00

Earnings Estimates

as of 1:00 ET PM 11/26/2021
Current Qtr
(12/2021)
Next Qtr
(03/2022)
Consensus Estimate $-0.07 $-0.03
# of Estimates 2 1
High Estimate $-0.03 $-0.03
Low Estimate $-0.10 $-0.03
Year Ago EPS $-0.09 $-0.09
Year Over Year Growth Estimate -27.78% -66.67%
Current Yr
(12/2021)
Next Yr
(12/2022)
Consensus Estimate $-0.22 $-0.16
# of Estimates 2 2
High Estimate $-0.17 $-0.06
Low Estimate $-0.26 $-0.25
Year Ago EPS $-0.77 $-0.22
Year Over Year Growth Estimate -72.08% -27.91%
Current Qtr
(12/2021)
Next Qtr
(03/2022)
Current Year
(12/2021)
Next Year
(12/2022)
Consensus Estimate $-0.07 $-0.03 $-0.22 $-0.16
# of Estimates 2 1 2 2
High Estimate $-0.03 $-0.03 $-0.17 $-0.06
Low Estimate $-0.10 $-0.03 $-0.26 $-0.25
Year Ago EPS $-0.09 $-0.09 $-0.77 $-0.22
Year Over Year Growth Estimate -27.78% -66.67% -72.08% -27.91%

Insider Information Summary

as of 10/31/2021
% Insiders - 35.08%
% Remaining Total Shares - 64.92%
Current 1 Month
Net Insider Transaction -9.36 K 11.07 K
Shares Bought 0.00 35.21 K
Shares Sold 9.36 K 24.14 K

Insider Activity

Transaction Date Insider/Title Transaction Type Market Value Shares Average Price Current Holdings

LATEST NEWS

Recent Articles from TheStreet

Coronavirus Outbreaks, Poor Vaccine Access, Weak Policy Pushes IMF To Downgrade Global Economic Outlook

BioNTech, Pfizer, J&J and Moderna Developing Omicron Vaccines

Pfizer Expects To Have A New Vaccine Ready In Six Weeks

Nvidia CEO Jensen Huang

Jim Cramer Talks With Nvidia CEO Jensen Huang

CEO describes a time when every store and drive-through will have an automated avatar -- powered by its chips -- that doesn't make mistakes.

China's State Media Moves To Reassure Rattled Investors After Rout Wiped US$574 Billion Off Stock Market

Can Nasdaq, S&P 500 Still Hit New All-Time Highs in 2021?

The stock market is technically in one of its most bullish periods of the year, but after Friday's pullback, investors are worried. Here's how to proceed.

Disney Lead

Encanto, House of Gucci Lead Hopeful Holiday Movie Theater Resurgence

Ticket sales are strong, if only half of pre-pandemic levels, as fears about the Omicron variant abound.

Jim Cramer: Jack Dorsey Can’t Do Both Jobs

'Teaching Luke How To Use The Force': Twitter Weighs in on Dorsey's Exit

As news broke that Jack Dorsey would be stepping down as CEO of Twitter, the social media platform lit up with both commentary and sarcasm.

Amazon Lead

Amazon Predicts It Will Pass UPS and Fedex as Biggest U.S. Shipper

To deal with supply chain disruption, Amazon is using its own trucks and planes and shipping goods to new ports, it said.

Nerdwallet Gas Discounts

NerdWallet Initiated Buy With $40 Price Target at Bank of America

'[Strong] revenue and margin growth, vertical growth initiatives [and] international expansion' will boost NerdWallet, Bank of America says.

Stocks Close Higher as Wall Street Dissects New Tax Laws

Stocks End Higher as Biden Says Omicron Response Avoids Lockdowns

Stocks close higher as President Joe Biden says the Omicron variant is 'a cause for concern, not a cause for panic.'

Wall Street Lead

5 Top Decliners for Monday Amid Stock Rally

Stocks rebound from Friday's selloff as markets bet that the Omicron variant may not be as bad as had been originally feared.

Money Challenges thumb

Nearly Two-Thirds of Americans Worried About Their Jobs: Bankrate

A Bankrate survey finds 3 in 5 Americans are concerned about the jobs and income sources.